Browsing Category

45046 posts
Dematic Expands Flexible Automation Capabilities Through GreyOrange Partnering Relationship

Dematic Expands Flexible Automation Capabilities Through GreyOrange Partnering Relationship

AI-powered capabilities help customers increase flexibility, optimize operations, and get more value…
Bybit P2P Super Deal Returns with Guaranteed Rewards

Bybit P2P Super Deal Returns with Guaranteed Rewards

DUBAI, UAE, April 14, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency…
Urban Onsen Sanctuary: FUFU Tokyo Ginza Named to TIME's World's Greatest Places of 2026

Urban Onsen Sanctuary: FUFU Tokyo Ginza Named to TIME's World's Greatest Places of 2026

TOKYO, April 14, 2026 /PRNewswire/ — Kato Pleasure Group proudly announces that…

Advances in Parkinson's Disease Cell Therapy: XellSmart Launches a Multicenter Phase II Clinical Trial Following Encouraging Phase I Results

SUZHOU, China, April 14, 2026 /PRNewswire/ — In April 2026, XellSmart officially launches…

IDC Report: Dreame Robot Vacuums Achieve Over 100% Year-on-Year Growth, Strengthen Southeast Asia Leadership with X60 Ultra Launch

HONG KONG, April 14, 2026 /PRNewswire/ — Dreame Technology recorded exceptional global…
Blaize Announces Expected First Quarter 2026 Revenue and Newly Awarded Contract with NeoTensr Anticipated to Generate .0 Million in Revenue

Blaize Announces Expected First Quarter 2026 Revenue and Newly Awarded Contract with NeoTensr Anticipated to Generate $50.0 Million in Revenue

First quarter 2026 revenue expected to be $2.7 million, impacted by memory…

LGHL ANNOUNCES THAT ITS WHOLLY-OWNED SUBSIDIARY HAS BEEN GRANTED EXCLUSIVITY TO FURTHER NEGOTIATIONS AND THE ENTERING INTO OF A FORMAL AGREEMENT IN RESPECT OF THE PROPOSED RESTRUCTURING OF SKYFAME REALTY (HOLDINGS) LIMITED (IN LIQUIDATION)

SINGAPORE, April 14, 2026 /PRNewswire/ — Lion Group Holding Ltd. (the "Company"…

Phrontline Biopharma Presents Preclinical Data for TJ106, a Biparatopic HER2 Dual-Payload ADC, at American Association for Cancer Research Annual Meeting 2026

Data Demonstrate Activity in HER2-Low and ADC-Resistant Tumor Models, Supporting Advancement Toward…